评论:全基因组关联研究在非洲裔美国人炎症性肠病患者中识别出非洲特异性易感位点
该研究对2345例非洲裔美国人炎症性肠病(IBD)患者和5002例对照进行两项高密度全基因组扫描,在溃疡性结肠炎(UC)中检出HLA-DRB1及非洲特异性ZNF649、LSAMP位点达全基因组显著性,在IBD中检出USP25达全基因组显著性,克罗恩病(CD)未检出全基因组显著关联。研究还复制了9个既往IBD相关基因,并发现部分基因具有非洲特异性等位基因关联模式。
要点
- 在非洲裔美国人UC中检出HLA-DRB1及非洲特异性ZNF649、LSAMP位点达全基因组显著性。
- 在IBD中检出USP25达全基因组显著性,CD未检出全基因组显著关联。
- 复制了9个既往IBD相关基因,部分基因显示非洲特异性等位基因关联模式。
核心结论
- 在非洲裔美国人IBD全基因组关联研究中识别出仅在该人群与UC相关的位点,并复制了欧洲人群中发现的IBD、CD和UC位点。
- 仅在非洲裔人群中检出与IBD风险相关的变异,表明在歐洲血统以外人群研究IBD及其他复杂疾病遗传学的重要性。
研究设计与样本
- 两项高密度全基因组扫描,纳入2345例非洲裔美国人IBD患者(1646例CD、583例UC、116例未分类IBD)和5002例无IBD对照。
- 对照来自Health Retirement Study和Kaiser Permanente数据库。
- 在荟萃分析中P < 5.0 × 10−8且每项扫描中名义证据P < .05的单核苷酸多态性(SNP)被认为具有全基因组显著性。
主要发现
- UC中检出HLA-DRB1及非洲特异性ZNF649、LSAMP的SNP达全基因组显著性。
- IBD中检出USP25的SNP达全基因组显著性。
- CD中未检出全基因组显著关联。
- 9个既往IBD相关基因含复制显著证据的SNP(P < 1.6 × 10−6):IBD为ADCY3、CXCR6、HLA-DRB1至HLA-DQA1(条件分析达全基因组显著性)、IL12B、PTGER4和TNC;CD为IL23R、PTGER4和SNX20(与NOD2强连锁不平衡);UC为KCNQ2(邻近TNFRSF6B)。
- TNC(邻近TNFSF15)、CXCR6及HLA位点IBD相关基因的SNP具有非洲特异性等位基因的独特关联模式。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: The inflammatory bowel diseases (IBD) ulcerative colitis (UC) and Crohn’s disease (CD) cause significant morbidity and are increasing in prevalence among all populations, including African Americans. More than 200 susceptibility loci have been identified in populations of predominantly European ancestry, but few loci have been associated with IBD in other ethnicities. METHODS: We performed 2 high-density, genome-wide scans comprising 2345 cases of African Americans with IBD (1646 with CD, 583 with UC, and 116 inflammatory bowel disease unclassified) and 5002 individuals without IBD (controls, identified from the Health Retirement Study and Kaiser Permanente database). Single-nucleotide polymorphisms (SNPs) associated at P < 5.0 × 10−8 in meta-analysis with a nominal evidence (P < .05) in each scan were considered to have genome-wide significance. RESULTS: We detected SNPs at HLA-DRB1, and African-specific SNPs at ZNF649 and LSAMP, with associations of genome-wide significance for UC. We detected SNPs at USP25 with associations of genome-wide significance for IBD. No associations of genome-wide significance were detected for CD. In addition, 9 genes previously associated with IBD contained SNPs with significant evidence for replication (P < 1.6 × 10−6): ADCY3, CXCR6, HLA-DRB1 to HLA-DQA1 (genome-wide signifi-cance on conditioning), IL12B, PTGER4, and TNC for IBD; IL23R, PTGER4, and SNX20 (in strong linkage disequilibrium with NOD2) for CD; and KCNQ2 (near TNFRSF6B) for UC. Several of these genes, such as TNC (near TNFSF15), CXCR6, and genes associated with IBD at the HLA locus, contained SNPs with unique association patterns with African-specific alleles. CONCLUSIONS: We performed a genome-wide association study of African Americans with IBD and identified loci associated with UC in only this population; we also replicated IBD, CD, and UC loci identified in European populations. The detection of variants associated with IBD risk in only people of African descent demonstrates the importance of studying the genetics of IBD and other complex diseases in populations beyond those of European ancestry.
引用
- Misra R, Arebi N. Re: Genome-Wide Association Study Identifies African-Specific Susceptibility Loci in African Americans With Inflammatory Bowel Disease. Gastroenterology. 2017. PMID: 28478146. doi:10.1053/j.gastro.2017.02.041
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。